The major aim of all vaccination strategies is disease reduction goals by getting high levels of immunity in the targeted group of people via adequate vaccination coverage and vaccine effectiveness. The idea is to boost immune system of individuals to prevent the spread of the disease.
These are some different type of vaccination strategies given below:
Pulse vaccination strategy: The pulse vaccination strategy is the process used to eliminate an epidemic by repeatedly vaccinating a group of people at risk, over a defined age range, until the spread of the microbe has been come to an end. It is mostly used during the time of polio and measles epidemics to quickly end the spread and contain the outbreak.
Ring vaccination: The method of vaccination of all infected individuals in a prescribed area around an outbreak of an infectious disease. The Ring vaccination process helps to controls an outbreak by monitoring and vaccinating a ring of people around each infected individual. The idea is to boost immune system of individuals to prevent the spread of the disease.
Cocooning (immunization): Cocooning process also known as the Cocoon Strategy, is an immunization strategy to protect young child and other vulnerable individuals from the infectious diseases by vaccinating those who are in close contact with them. If the groups of people most likely to transmit an infection are immune, their immunity creates a "cocoon" of protection around the newborn or the vulnerable persons.
Title : Vaccines and monoclonal antibodies in the prolonged treatment of non-small cell lung cancer: 20 years of follow-up
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title : Observational study post emergency use authorization of itolizumab in the treatment of COVID-19
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title : Vaccine for AML: 2023 and beyond
Stefan Gluck, Vice President, Global Medical Affairs at Celgene Corporation, United States
Title : Purification process development of COVID antigens to identify sera needed for plasma therapy
Sushmita Koley, Senior Scientist Bio-Rad Laboratories, United States
Title : Lessons that can be learned from the rollout of the COVID-19 vaccine and the acceptance of vaccination from healthcare professionals, frontline workers and patients that need to be considered in developing a vaccine
Regina Au, BioMarketing Insight, United States
Title : Lessons learned for the future of social listening to address vaccine misinformation
Joe Smyser, The Public Good Projects, United States
Title : Why Low-Energy-Electron Irradiation might be a potential game changer for vaccine development, manufacturing, and pandemics prevention
Daniel Becker, KyooBe Tech GmbH, Germany
Title : National immunization management system- NIMS
Kashif Zulfiqar, Project Manager - NADRA, Pakistan
Title : Medicinal synthetic aluminum-magnesium silicate {Al4 (SiO4)3 + 3Mg2SiO4?2Al2 Mg3 (SiO4)3} effective for: Viral diseases; Tumors; Antimicrobial resistant infections
Maduike Chiehiura Onwubiko Ezeibe, Michael Okpara University of Agriculture, Nigeria
Title : Moving the needle for covid-19 vaccinations in Nigeria through leadership, accountability, and transparency
Fejiro Chinye Nwoko, Nigeria Solidarity Support Fund, Nigeria